AI in Medical Diagnostics Market Size, Share, and Growth Analysis, By Component (Software, Services), By End User (Hospitals, Diagnostic Imaging Centers), By Modality, By Application, By Region - Industry Forecast 2025-2032
ÀÇ·á Áø´Ü ºÐ¾ß AI ½ÃÀå ±Ô¸ð : ÃÖÁ¾»ç¿ëÀÚº°¡¤CAGR(2025³â-2032³â)
½ÃÀå °³¿ä
º´¿ø
Áø´Ü¿µ»ó¼¾ÅÍ
Áø´Ü½ÇÇè½Ç
±âŸ ÃÖÁ¾»ç¿ëÀÚ
ÀÇ·á Áø´Ü ºÐ¾ß AI ½ÃÀå ±Ô¸ð : ¸ð´Þ¸®Æ¼º°¡¤CAGR(2025³â-2032³â)
½ÃÀå °³¿ä
¿µ»ó Áø´Ü Àåºñ
ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ
X¼±
ÀÚ±â°ø¸í¿µ»ó(MRI)
ÃÊÀ½ÆÄ
¸¾¸ð±×·¡ÇÇ
±âŸ ¿µ»ó Áø´Ü¹ý
Áø´Ü ¸ð´Þ¸®Æ¼
¸é¿ªÃøÁ¤
ÀÓ»óÈÇÐ
Ç÷¾×ÇÐ
¹Ì»ý¹°ÇÐ
±âŸ Áø´Ü ¸ð´Þ¸®Æ¼
ÀÇ·á Áø´Ü ºÐ¾ß AI ½ÃÀå ±Ô¸ð : ¿ëµµº°¡¤CAGR(2025³â-2032³â)
½ÃÀå °³¿ä
In Vivo Áø´Ü ¿ëµµ
¹æ»ç¼±°ú
Á¾¾çÇÐ
½ÉÀ庴ÇÐ
½Å°æÇÐ
»êºÎÀΰú
¾È°ú
±âŸ In Vivo ¿ëµµ
In Vitro Áø´Ü ¿ëµµ
°¨¿°Áõ
³»ºÐºñÇÐ
ÀÚ°¡¸é¿ª °Ë»ç
Ç÷¾×°Ë»ç¿Í ÀÀ°í °Ë»ç
±âŸ In Vitro ¿ëµµ
ÀÇ·á Áø´Ü ºÐ¾ß AI ½ÃÀå ±Ô¸ð¡¤CAGR(2025³â-2032³â)
ºÏ¹Ì
¹Ì±¹
ij³ª´Ù
À¯·´
µ¶ÀÏ
½ºÆäÀÎ
ÇÁ¶û½º
¿µ±¹
ÀÌÅ»¸®¾Æ
±âŸ À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
Áß±¹
Àεµ
ÀϺ»
Çѱ¹
±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
¶óƾ¾Æ¸Þ¸®Ä«
ºê¶óÁú
±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
GCC ±¹°¡
³²¾ÆÇÁ¸®Ä«
±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
°æÀï Á¤º¸
ÁÖ¿ä 5°³»ç ºñ±³
ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×(2024³â)
ÁÖ¿ä ½ÃÀå ±â¾÷ÀÌ Ã¤ÅÃÇÑ Àü·«
ÃÖ±Ù ½ÃÀå µ¿Çâ
±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â)
ÁÖ¿ä ±â¾÷ °³¿ä
±â¾÷ »ó¼¼
Á¦Ç° Æ÷Æ®Æú¸®¿À ºÐ¼®
±â¾÷ ºÎ¹®º° Á¡À¯À² ºÐ¼®
¸ÅÃâ Àü³â´ëºñ ºñ±³(2022³â-2024³â)
ÁÖ¿ä ±â¾÷ °³¿ä
Microsoft
Nvidia Corporation
Merative
Google(Alphabet, Inc.)
Intel Corporation
Siemens Healthineers Ag
GE Healthcare
Advanced Micro Devices, Inc.
Koninklijke Philips N.V.
Digital Diagnostics, Inc.
Informai
Heartflow, Inc.
Enlitic, Inc.
Butterfly Network, Inc.
Nano-X Imaging Ltd.
Viz.Ai, Inc.
Quibim
Qure.Ai
Therapixel
Aidoc
°á·Ð°ú Á¦¾È
LSH
¿µ¹® ¸ñÂ÷
¿µ¹®¸ñÂ÷
Global AI in Medical Diagnostics Market size was valued at USD 1.4 billion in 2023 and is poised to grow from USD 1.74 billion in 2024 to USD 10.06 billion by 2032, growing at a CAGR of 24.5% during the forecast period (2025-2032).
The global AI in medical diagnostics market is experiencing significant growth, driven by the increasing demand for early disease detection, integration of AI into healthcare IT systems, and the shortage of diagnostic professionals. Governments and healthcare organizations worldwide are leveraging AI to enhance clinical decision-making and streamline diagnostic processes. A notable example is the UK's National Health Service (NHS), which, as of May 2024, deployed AI tools in radiology departments, drastically reducing chest X-ray turnaround times from 11 days to under 48 hours, thereby improving cancer detection and patient triaging. Additionally, collaboration among tech companies and academic institutions is fostering rapid innovation, further propelling the market, with advancements in imaging analytics, AI-powered pathology software, and predictive health models.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global AI in Medical Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global AI in Medical Diagnostics Market Segments Analysis
Global AI in Medical Diagnostics Market is segmented by Component, End User, Modality, Application and region. Based on Component, the market is segmented into Software, Services and Hardware. Based on End User, the market is segmented into Hospitals, Diagnostic Imaging Centers, Diagnostic Laboratories and Other End Users. Based on Modality, the market is segmented into Imaging Modalities and Diagnostics Modalities. Based on Application, the market is segmented into In Vivo Diagnostics Applications and In Vitro Diagnostics Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global AI in Medical Diagnostics Market
The global market for AI in medical diagnostics is rapidly evolving, driven by significant advancements in technologies such as deep learning, computer vision, and natural language processing. These innovations enable AI systems to effectively analyze and interpret intricate medical data, including imaging scans, pathology slides, and genetic information, with remarkable accuracy. As a result, the incorporation of AI-supported diagnostic tools is increasingly vital for healthcare professionals who seek to elevate the quality of care through enhanced decision-making capabilities and improved patient outcomes. This ongoing trend highlights the pivotal role that AI plays in transforming the landscape of medical diagnostics.
Restraints in the Global AI in Medical Diagnostics Market
The Global AI in Medical Diagnostics market faces significant constraints due to the substantial initial costs associated with AI implementations. These expenses encompass various elements such as infrastructure, software licenses, integration with existing hospital systems, and essential workforce training. Such financial burdens can be particularly daunting for small and medium-sized hospitals and diagnostic laboratories, especially in developing regions where budget limitations are a common issue. As a result, the high entry costs may hinder the adoption of AI technologies in medical diagnostics, ultimately impacting the overall growth and advancement of the market in these areas.
Market Trends of the Global AI in Medical Diagnostics Market
The Global AI in Medical Diagnostics market is witnessing a significant expansion, particularly in radiology and pathology, where advanced deep learning algorithms are revolutionizing disease detection. By 2025, a notable percentage of radiology departments in North America and Europe are expected to adopt AI-driven tools like Aidoc and PathAI, enhancing diagnostic accuracy for conditions such as cancers and brain hemorrhages while substantially reducing turnaround times. This trend underscores a growing reliance on AI technology in clinical settings, emphasizing its critical role in improving patient outcomes and facilitating differential diagnoses. Overall, the integration of AI into these fields signifies a transformative shift in healthcare delivery.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Technology Analysis
Case Studies
Global AI in Medical Diagnostics Market Size by Component & CAGR (2025-2032)
Market Overview
Software
Imaging Software
Predictive Analysis Software
Diagnostic Software
Services
Hardware
Processors
MPU
GPU
FPGA
ASIC
Memory
Networks
Adapter
Switch
Interconnect
Global AI in Medical Diagnostics Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals
Diagnostic Imaging Centers
Diagnostic Laboratories
Other End Users
Global AI in Medical Diagnostics Market Size by Modality & CAGR (2025-2032)
Market Overview
Imaging Modalities
Computed Tomography
X-Ray
Magnetic Resonance Imaging
Ultrasound
Mammography
Other Imaging Modalities
Diagnostics Modalities
Immunoassay
Clinical Chemistry
Hematology
Microbiology
Other Diagnostic Modalities
Global AI in Medical Diagnostics Market Size by Application & CAGR (2025-2032)
Market Overview
In Vivo Diagnostics Applications
Radiology
Oncology
Cardiology
Neurology
Obstetrics/Gynecology
Ophthalmology
Other In Vivo Applications
In Vitro Diagnostics Applications
Infectious Diseases
Endocrinology
Autoimmune Testing
Blood Screening and Coagulation Testing
Other In Vitro Applications
Global AI in Medical Diagnostics Market Size & CAGR (2025-2032)
North America (Component, End User, Modality, Application)
US
Canada
Europe (Component, End User, Modality, Application)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Component, End User, Modality, Application)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Component, End User, Modality, Application)
Brazil
Rest of Latin America
Middle East & Africa (Component, End User, Modality, Application)